CL2013002895A1 - Compuestos derivados de 7,8-dihidro-5h-pteridin-6-ona, utiles como intermediarios en la sintesis de compuestos derivados de pteridinona (divisional de la solicitud 3123-2005). - Google Patents

Compuestos derivados de 7,8-dihidro-5h-pteridin-6-ona, utiles como intermediarios en la sintesis de compuestos derivados de pteridinona (divisional de la solicitud 3123-2005).

Info

Publication number: CL2013002895A1
Authority: CL; Chile
Prior art keywords: compounds derived; pteridinone; pteridin; divisional; dihydro
Prior art date: 2004-12-02

Application number

CL2013002895A

Other languages

English (en)

Inventor

Guenter Linz

Adil Duran

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-02

Filing date

2013-10-09

Publication date

2014-03-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35923724&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2013002895(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-10-09 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

2014-03-14 Publication of CL2013002895A1 publication Critical patent/CL2013002895A1/es

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Oncology (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Catalysts (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

CL2013002895A 2004-12-02 2013-10-09 Compuestos derivados de 7,8-dihidro-5h-pteridin-6-ona, utiles como intermediarios en la sintesis de compuestos derivados de pteridinona (divisional de la solicitud 3123-2005). CL2013002895A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE102004058337A DE102004058337A1 (de)	2004-12-02	2004-12-02	Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten

Publications (1)

Publication Number	Publication Date
CL2013002895A1 true CL2013002895A1 (es)	2014-03-14

Family

ID=35923724

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL2013002895A CL2013002895A1 (es)	2004-12-02	2013-10-09	Compuestos derivados de 7,8-dihidro-5h-pteridin-6-ona, utiles como intermediarios en la sintesis de compuestos derivados de pteridinona (divisional de la solicitud 3123-2005).

Country Status (34)

Country	Link
US (9)	US7238807B2 (es)
EP (2)	EP2436685B1 (es)
JP (1)	JP5164574B2 (es)
KR (2)	KR101362131B1 (es)
CN (3)	CN101065381B (es)
AR (1)	AR053100A1 (es)
AU (1)	AU2005311308B2 (es)
BR (1)	BRPI0518601A2 (es)
CA (1)	CA2588857C (es)
CL (1)	CL2013002895A1 (es)
CY (1)	CY1113625T1 (es)
DE (1)	DE102004058337A1 (es)
DK (2)	DK1819706T3 (es)
EA (1)	EA012624B1 (es)
ES (2)	ES2548680T3 (es)
HR (1)	HRP20120980T1 (es)
HU (1)	HUE027689T2 (es)
IL (1)	IL183568A (es)
ME (1)	ME01470B (es)
MX (1)	MX2007006549A (es)
MY (1)	MY147459A (es)
NO (1)	NO20072283L (es)
NZ (1)	NZ556182A (es)
PE (2)	PE20090488A1 (es)
PL (2)	PL1819706T3 (es)
PT (1)	PT1819706E (es)
RS (1)	RS52533B (es)
SG (2)	SG141461A1 (es)
SI (1)	SI1819706T1 (es)
TW (1)	TWI362391B (es)
UA (1)	UA89390C2 (es)
UY (1)	UY29233A1 (es)
WO (1)	WO2006058876A1 (es)
ZA (1)	ZA200703368B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6861422B2 (en) *	2003-02-26	2005-03-01	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
DE102004029784A1 (de) *	2004-06-21	2006-01-05	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004033670A1 (de) *	2004-07-09	2006-02-02	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
US7759485B2 (en) *	2004-08-14	2010-07-20	Boehringer Ingelheim International Gmbh	Process for the manufacture of dihydropteridinones
US20060035903A1 (en) *	2004-08-14	2006-02-16	Boehringer Ingelheim International Gmbh	Storage stable perfusion solution for dihydropteridinones
US7728134B2 (en) *	2004-08-14	2010-06-01	Boehringer Ingelheim International Gmbh	Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
US20060074088A1 (en) *	2004-08-14	2006-04-06	Boehringer Ingelheim International Gmbh	Dihydropteridinones for the treatment of cancer diseases
US20060058311A1 (en) *	2004-08-14	2006-03-16	Boehringer Ingelheim International Gmbh	Combinations for the treatment of diseases involving cell proliferation
EP1630163A1 (de) *	2004-08-25	2006-03-01	Boehringer Ingelheim Pharma GmbH & Co.KG	Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1632493A1 (de) *	2004-08-25	2006-03-08	Boehringer Ingelheim Pharma GmbH & Co.KG	Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102004058337A1 (de) *	2004-12-02	2006-06-14	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
US7439358B2 (en) *	2006-02-08	2008-10-21	Boehringer Ingelheim International Gmbh	Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
NZ570530A (en)	2006-02-14	2011-09-30	Vertex Pharma	Pharmaceutical compositions comprising 6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4)diazepine derivatives
JP4958461B2 (ja) *	2006-03-30	2012-06-20	富士フイルム株式会社	近赤外吸収色素含有硬化性組成物
WO2008093075A2 (en)	2007-02-01	2008-08-07	Astrazeneca Ab	5,6,7,8-tetrahydropteridine derivatives as hsp90 inhibitors
EP2185559A1 (en) *	2007-08-03	2010-05-19	Boehringer Ingelheim International GmbH	Crystalline form of a dihydropteridione derivative
EP2100894A1 (en)	2008-03-12	2009-09-16	4Sc Ag	Pyridopyrimidines used as Plk1 (polo-like kinase) inhibitors
CN102020643A (zh)	2009-09-22	2011-04-20	上海恒瑞医药有限公司	二氢喋啶酮类衍生物、其制备方法及其在医药上的应用
CN103492391A (zh)	2009-09-25	2014-01-01	沃泰克斯药物股份有限公司	用于制备用作蛋白激酶抑制剂的嘧啶衍生物的方法
MX2012003484A (es)	2009-09-25	2012-04-20	Vertex Pharma	Metodos para preparar derivados de pirimidina utiles como inhibidores de proteina cinasa.
US8546566B2 (en)	2010-10-12	2013-10-01	Boehringer Ingelheim International Gmbh	Process for manufacturing dihydropteridinones and intermediates thereof
US9358233B2 (en)	2010-11-29	2016-06-07	Boehringer Ingelheim International Gmbh	Method for treating acute myeloid leukemia
AR085406A1 (es)	2011-02-25	2013-09-25	Takeda Pharmaceutical	Oxazinopteridinas y oxazinopteridinonas n-sustituidas
US9370535B2 (en)	2011-05-17	2016-06-21	Boehringer Ingelheim International Gmbh	Method for treatment of advanced solid tumors
TW201414734A (zh)	2012-07-10	2014-04-16	Takeda Pharmaceutical	氮雜吲哚衍生物
JP2016525532A (ja)	2013-07-26	2016-08-25	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	骨髄異形成症候群の処置
TW201620904A (zh)	2014-01-09	2016-06-16	武田藥品工業有限公司	氮雜吲哚衍生物
US9867831B2 (en)	2014-10-01	2018-01-16	Boehringer Ingelheim International Gmbh	Combination treatment of acute myeloid leukemia and myelodysplastic syndrome

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4032639A (en) *	1976-03-22	1977-06-28	American Home Products Corporation	2,3,4,4A-Tetrahydro-1H-pyrazino[1,2-a,]quinoxalin-5(6H)-ones and derivatives thereof for relieving hypertension
US4182872A (en) *	1976-03-22	1980-01-08	American Home Products Corporation	4-(Lower)alkyl-1-(o-nitrophenyl)piperazine-2-carboxylic acid chemical intermediates
NL8303657A (nl)	1983-10-24	1985-05-17	Pharmachemie Bv	Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
DE3537761A1 (de) *	1985-10-24	1987-04-30	Bayer Ag	Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
EP0347146B1 (en)	1988-06-16	1993-09-01	Smith Kline & French Laboratories Limited	Fused pyrimidine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
FR2645152B1 (fr) *	1989-03-30	1991-05-31	Lipha	3h-pteridinones-4, procedes de preparation et medicaments les contenant
US5043270A (en)	1989-03-31	1991-08-27	The Board Of Trustees Of The Leland Stanford Junior University	Intronic overexpression vectors
CA2029651C (en)	1989-11-17	2000-06-06	David D. Davey	Tricyclic pteridinones and a process for their preparation
US5198547A (en)	1992-03-16	1993-03-30	South Alabama Medical Science Foundation, Usa	Process for N5-formylating tetrahydropteridines
TW274550B (es) *	1992-09-26	1996-04-21	Hoechst Ag
EP1195372A1 (en)	1994-04-18	2002-04-10	Mitsubishi Pharma Corporation	N-heterocyclic substituted benzamide derivatives with antihypertensive activity
CO4410190A1 (es)	1994-09-19	1997-01-09	Lilly Co Eli	3-[4-(2-AMINOETOXI)-BENZOIL]-2-ARIL-6-HIDROXIBENZO [b] TIOFENO CRISTALINO
IL117923A (en)	1995-05-03	2000-06-01	Warner Lambert Co	Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
EP0825979B1 (en) *	1995-05-19	2001-01-03	Novartis AG	Process for the catalytic hydrogenation of aromatic nitro compounds
US5698556A (en) *	1995-06-07	1997-12-16	Chan; Carcy L.	Methotrexate analogs and methods of using same
HU226167B1 (hu)	1996-09-23	2008-05-28	Lilly Co Eli	Olanzapin-dihidrát D, elõállítása és az azt tartalmazó gyógyszerkészítmények
AP2001002068A0 (en) *	1998-08-11	2001-03-31	Pfizer Prod Inc	Substituted 1,8-naphthyridin-4(1H)-ones as phosphodiesterase 4 inhibitors.
NZ516872A (en)	1999-09-15	2003-10-31	Warner Lambert Co	Pteridinones as kinase inhibitors
GB2359551A (en)	2000-02-23	2001-08-29	Astrazeneca Uk Ltd	Pharmaceutically active pyrimidine derivatives
CA2401368A1 (en)	2000-03-06	2001-09-27	Warner-Lambert Company	5-alkylpyrido[2,3-d]pyrimidines tyrosine kinase inhibitors
DE10018783A1 (de)	2000-04-15	2001-10-25	Fresenius Kabi De Gmbh	Lagerstabile Infusionslösung des Ciprofloxacins mit verringertem Säuregehalt
US20020183292A1 (en) *	2000-10-31	2002-12-05	Michel Pairet	Pharmaceutical compositions based on anticholinergics and corticosteroids
DE10058119A1 (de) *	2000-11-22	2002-05-23	Bayer Ag	Pepinotan-Kit
US6756374B2 (en)	2001-01-22	2004-06-29	Hoffmann-La Roche Inc.	Diaminothiazoles having antiproliferative activity
WO2002076954A1 (en)	2001-03-23	2002-10-03	Smithkline Beecham Corporation	Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
WO2002076985A1 (en)	2001-03-23	2002-10-03	Smithkline Beecham Corporation	Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
US20030055026A1 (en) *	2001-04-17	2003-03-20	Dey L.P.	Formoterol/steroid bronchodilating compositions and methods of use thereof
US6806272B2 (en) *	2001-09-04	2004-10-19	Boehringer Ingelheim Pharma Kg	Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
JP3876254B2 (ja)	2001-09-04	2007-01-31	ベーリンガーインゲルハイムファルマゲゼルシャフトミットベシュレンクテルハフツングウントコンパニーコマンディトゲゼルシャフト	新規なジヒドロプテリジノン、その製造方法及びその医薬組成物としての使用
ATE526013T1 (de) *	2001-12-14	2011-10-15	Merck Serono Sa	Verfahren zur herbeiführung einer ovulation über einen nicht-polypeptid-camp-spiegel-modulator
RU2004135533A (ru)	2002-05-03	2005-07-20	Шеринг Акциенгезельшафт (De)	Тиазолидиноны и их применение в качестве ингибиторов polo- подобной киназы
RU2296758C2 (ru)	2002-08-08	2007-04-10	Смитклайн Бичем Корпорейшн	Производные тиофена
US6862422B2 (en) *	2003-02-12	2005-03-01	Kabushiki Kaisha Toshiba	Image forming apparatus and image forming method having pressing members for pressing a belt-like member
HRP20050735B1 (hr)	2003-02-26	2013-08-31	Boehringer Ingelheim Pharma Gmbh & Co.Kg	Dihidropteridinoni, metoda za njihovu proizvodnju i upotrebu u obliku lijekova
US6861422B2 (en) *	2003-02-26	2005-03-01	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
US20040180898A1 (en) *	2003-03-03	2004-09-16	Bang-Chi Chen	Processes for preparing imidazoquinoxalinones, heterocyclic-substituted imidazopyrazinones, imidazoquinoxalines and heterocyclic-substituted imidazopyrazines
JP2006523224A (ja)	2003-03-26	2006-10-12	ワイス	免疫原性組成物および方法
WO2004093848A2 (en)	2003-04-14	2004-11-04	Vectura Ltd	Dry power inhaler devices and dry power formulations for enhancing dosing efficiency
EP1708715A1 (de) *	2004-01-17	2006-10-11	Boehringer Ingelheim International GmbH	Verwendung von substituierten pteridinen zur behandlung von atemwegserkrankungen
DE102004002557A1 (de) *	2004-01-17	2005-08-04	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verwendung von substituierten Pyrimido(5,4-d)pyrimidinen zur Behandlung von Atemwegserkrankungen
DE102004029784A1 (de) *	2004-06-21	2006-01-05	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004033670A1 (de) *	2004-07-09	2006-02-02	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
DE102004034623A1 (de) *	2004-07-16	2006-02-02	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue 6-Formyl-tetrahydropteridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7728134B2 (en) *	2004-08-14	2010-06-01	Boehringer Ingelheim International Gmbh	Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
US7759485B2 (en)	2004-08-14	2010-07-20	Boehringer Ingelheim International Gmbh	Process for the manufacture of dihydropteridinones
US20060058311A1 (en)	2004-08-14	2006-03-16	Boehringer Ingelheim International Gmbh	Combinations for the treatment of diseases involving cell proliferation
US20060035903A1 (en)	2004-08-14	2006-02-16	Boehringer Ingelheim International Gmbh	Storage stable perfusion solution for dihydropteridinones
US20060074088A1 (en) *	2004-08-14	2006-04-06	Boehringer Ingelheim International Gmbh	Dihydropteridinones for the treatment of cancer diseases
EP1630163A1 (de) *	2004-08-25	2006-03-01	Boehringer Ingelheim Pharma GmbH & Co.KG	Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1632493A1 (de) *	2004-08-25	2006-03-08	Boehringer Ingelheim Pharma GmbH & Co.KG	Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
WO2006021547A1 (de) *	2004-08-26	2006-03-02	Boehringer Ingelheim International Gmbh	Pteridinone als plk (polo like kinase) inhibitoren
EP1784406A1 (de) *	2004-08-27	2007-05-16	Boehringer Ingelheim International GmbH	Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE102004058337A1 (de) *	2004-12-02	2006-06-14	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
JP2009503014A (ja)	2005-08-03	2009-01-29	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	呼吸器系疾患の治療におけるジヒドロプテリジノン
US7439358B2 (en)	2006-02-08	2008-10-21	Boehringer Ingelheim International Gmbh	Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
US20090023733A1 (en)	2006-03-07	2009-01-22	Peter Cage	Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing Them
EP2185559A1 (en)	2007-08-03	2010-05-19	Boehringer Ingelheim International GmbH	Crystalline form of a dihydropteridione derivative

2004
- 2004-12-02 DE DE102004058337A patent/DE102004058337A1/de not_active Withdrawn
2005
- 2005-11-22 US US11/284,836 patent/US7238807B2/en not_active Ceased
- 2005-11-29 SI SI200531631T patent/SI1819706T1/sl unknown
- 2005-11-29 UA UAA200706986A patent/UA89390C2/ru unknown
- 2005-11-29 CN CN2005800406546A patent/CN101065381B/zh not_active Expired - Fee Related
- 2005-11-29 BR BRPI0518601-3A patent/BRPI0518601A2/pt not_active IP Right Cessation
- 2005-11-29 KR KR1020077015136A patent/KR101362131B1/ko not_active Expired - Fee Related
- 2005-11-29 RS RS20120519A patent/RS52533B/sr unknown
- 2005-11-29 ME MEP-2012-124A patent/ME01470B/me unknown
- 2005-11-29 CN CN201010593286.0A patent/CN102093361B/zh not_active Expired - Fee Related
- 2005-11-29 PL PL05823799T patent/PL1819706T3/pl unknown
- 2005-11-29 DK DK05823799.1T patent/DK1819706T3/da active
- 2005-11-29 HR HRP20120980TT patent/HRP20120980T1/hr unknown
- 2005-11-29 HU HUE11189691A patent/HUE027689T2/hu unknown
- 2005-11-29 EA EA200701164A patent/EA012624B1/ru not_active IP Right Cessation
- 2005-11-29 EP EP11189691.6A patent/EP2436685B1/de not_active Expired - Lifetime
- 2005-11-29 SG SG200802431-7A patent/SG141461A1/en unknown
- 2005-11-29 SG SG201000003-2A patent/SG158848A1/en unknown
- 2005-11-29 CN CN2010105934512A patent/CN102070637B/zh not_active Expired - Fee Related
- 2005-11-29 ES ES11189691.6T patent/ES2548680T3/es not_active Expired - Lifetime
- 2005-11-29 WO PCT/EP2005/056291 patent/WO2006058876A1/de not_active Ceased
- 2005-11-29 PT PT58237991T patent/PT1819706E/pt unknown
- 2005-11-29 MX MX2007006549A patent/MX2007006549A/es active IP Right Grant
- 2005-11-29 EP EP05823799A patent/EP1819706B1/de not_active Expired - Lifetime
- 2005-11-29 PL PL11189691T patent/PL2436685T3/pl unknown
- 2005-11-29 NZ NZ556182A patent/NZ556182A/en not_active IP Right Cessation
- 2005-11-29 JP JP2007543838A patent/JP5164574B2/ja not_active Expired - Lifetime
- 2005-11-29 AU AU2005311308A patent/AU2005311308B2/en not_active Ceased
- 2005-11-29 UY UY29233A patent/UY29233A1/es not_active Application Discontinuation
- 2005-11-29 DK DK11189691.6T patent/DK2436685T3/en active
- 2005-11-29 ES ES05823799T patent/ES2395829T3/es not_active Expired - Lifetime
- 2005-11-29 CA CA2588857A patent/CA2588857C/en not_active Expired - Fee Related
- 2005-11-29 KR KR1020127028659A patent/KR101395591B1/ko not_active Expired - Fee Related
- 2005-11-30 PE PE2009000418A patent/PE20090488A1/es not_active Application Discontinuation
- 2005-11-30 PE PE2005001388A patent/PE20061061A1/es not_active Application Discontinuation
- 2005-11-30 MY MYPI20055607A patent/MY147459A/en unknown
- 2005-12-01 TW TW094142312A patent/TWI362391B/zh not_active IP Right Cessation
- 2005-12-02 AR ARP050105040A patent/AR053100A1/es unknown
2007
- 2007-04-25 ZA ZA200703368A patent/ZA200703368B/xx unknown
- 2007-05-03 NO NO20072283A patent/NO20072283L/no not_active Application Discontinuation
- 2007-05-16 US US11/749,207 patent/US20070213534A1/en not_active Abandoned
- 2007-05-16 US US11/749,212 patent/US20070213530A1/en not_active Abandoned
- 2007-05-16 US US11/749,205 patent/US20070213529A1/en not_active Abandoned
- 2007-05-16 US US11/749,210 patent/US20070213531A1/en not_active Abandoned
- 2007-05-16 US US11/749,203 patent/US20070213528A1/en not_active Abandoned
- 2007-05-16 US US11/749,208 patent/US20070219369A1/en not_active Abandoned
- 2007-05-16 US US11/749,206 patent/US7626019B2/en active Active
- 2007-05-31 IL IL183568A patent/IL183568A/en not_active IP Right Cessation
2010
- 2010-08-05 US US12/850,993 patent/USRE43115E1/en not_active Expired - Lifetime
2012
- 2012-12-12 CY CY20121101215T patent/CY1113625T1/el unknown
2013
- 2013-10-09 CL CL2013002895A patent/CL2013002895A1/es unknown

Also Published As

Publication number	Publication date
DE102004058337A1 (de)	2006-06-14
AU2005311308A1 (en)	2006-06-08
MY147459A (en)	2012-12-14
ES2548680T3 (es)	2015-10-20
CY1113625T1 (el)	2016-06-22
SG158848A1 (en)	2010-02-26
EP1819706B1 (de)	2012-09-19
EP2436685B1 (de)	2015-07-01
CN102093361A (zh)	2011-06-15
KR20120136414A (ko)	2012-12-18
AR053100A1 (es)	2007-04-25
PE20061061A1 (es)	2006-11-10
CN101065381B (zh)	2011-03-30
CN102070637A (zh)	2011-05-25
HK1158199A1 (en)	2012-07-13
WO2006058876A1 (de)	2006-06-08
US7626019B2 (en)	2009-12-01
US20070213531A1 (en)	2007-09-13
BRPI0518601A2 (pt)	2008-11-25
HK1113489A1 (en)	2008-10-03
US20070213530A1 (en)	2007-09-13
PT1819706E (pt)	2012-12-06
CA2588857A1 (en)	2006-06-08
NZ556182A (en)	2009-08-28
DK2436685T3 (en)	2015-09-14
CA2588857C (en)	2013-10-08
TWI362391B (en)	2012-04-21
HK1158200A1 (en)	2012-07-13
SI1819706T1 (sl)	2013-01-31
KR101362131B1 (ko)	2014-02-19
JP2008521861A (ja)	2008-06-26
EA200701164A1 (ru)	2007-12-28
SG141461A1 (en)	2008-04-28
US7238807B2 (en)	2007-07-03
UA89390C2 (ru)	2010-01-25
CN102070637B (zh)	2012-09-26
EP1819706A1 (de)	2007-08-22
CN101065381A (zh)	2007-10-31
IL183568A0 (en)	2007-09-20
US20070213528A1 (en)	2007-09-13
ME01470B (me)	2014-04-20
KR101395591B1 (ko)	2014-05-16
ZA200703368B (en)	2008-09-25
US20070213534A1 (en)	2007-09-13
KR20070092252A (ko)	2007-09-12
HUE027689T2 (hu)	2021-12-28
US20070213529A1 (en)	2007-09-13
CN102093361B (zh)	2014-05-07
AU2005311308B2 (en)	2012-04-12
PE20090488A1 (es)	2009-05-27
JP5164574B2 (ja)	2013-03-21
US20060122393A1 (en)	2006-06-08
UY29233A1 (es)	2006-07-31
DK1819706T3 (da)	2013-01-02
US20070208027A1 (en)	2007-09-06
RS52533B (sr)	2013-04-30
PL1819706T3 (pl)	2013-03-29
US20070219369A1 (en)	2007-09-20
TW200628471A (en)	2006-08-16
PL2436685T3 (pl)	2015-11-30
IL183568A (en)	2015-02-26
USRE43115E1 (en)	2012-01-17
EP2436685A1 (de)	2012-04-04
ES2395829T3 (es)	2013-02-15
MX2007006549A (es)	2007-06-18
NO20072283L (no)	2007-06-28
EA012624B1 (ru)	2009-10-30
HRP20120980T1 (hr)	2012-12-31

Publication	Publication Date	Title
CL2013002895A1 (es)	2014-03-14	Compuestos derivados de 7,8-dihidro-5h-pteridin-6-ona, utiles como intermediarios en la sintesis de compuestos derivados de pteridinona (divisional de la solicitud 3123-2005).
DE602006010132D1 (de)	2009-12-17	Zwischenprodukte für die Herstellung von Trans-5-Chlor-2-Methyl-2,3,3a,12b-Tetrahydro-1h-DibenzÄ2,3:6,7ÜOxepinoÄ4,5-cÜPyrrol
CY1109998T1 (el)	2014-09-10	Ενδυναμωτες υποδοχεων γλουταμινικου
WO2006120208A8 (en)	2007-09-07	Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
MX291201B (es)	2011-10-20	Produccion fermentativa de compuestos quimicos finos.
DK1824856T3 (da)	2014-01-27	2,4 (4,6)-pyrimidinderivater
DE602006020482D1 (de)	2011-04-14	1,5-substituierte indol-2-yl amidderivative
DE60328138D1 (de)	2009-08-06	Zwischenprodukte für die Herstellung von Dioxan-2-alkylcarbamaten
SI1869056T1 (sl)	2011-02-28	Novi 5-substituirani 7-amino-(1,3)tiazolo(4,5-d) pirimidinski derivati
WO2005075412A3 (en)	2005-12-29	Norbornane based cycloaliphatic compounds containing nitrile groups
TW200745039A (en)	2007-12-16	Isotopically substituted pantoprazole
WO2007016029A3 (en)	2007-05-18	Diazepinoquinolines, synthesis thereof, and intermediates thereto
DE60323748D1 (de)	2008-11-06	1,3-diaza-dibenzoazulene als inhibitoren der produfür deren herstellung
ITMI20030346A1 (it)	2004-08-28	Procedimento per la produzione di mesitilene.
NO20050885D0 (no)	2005-02-18	Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
ITMI20041920A1 (it)	2005-01-11	Processo per la preparazione di n, n-diisopropil-3-2-idrossi-5-metilfenil-3-fenil-propabammina
DE602006004566D1 (de)	2009-02-12	Substituierte pyrrole, zusammensetzungen, die dieshre verwendung
ITRM20010309A0 (it)	2001-06-04	Procedimento per la produzione di composti perfluoro-organici mediante florurazione elettrochimica.
EP1883628A4 (en)	2010-07-21	IMPROVED PROCESS FOR THE PREPARATION OF 3,5-DIETHYL-1,2-DIHYDRO-1-PHENYL-2-PROPYLPYRIDINE
ITRM20020434A0 (it)	2002-08-22	Procedimento per la sintesi di zolfo polimerico.
ITMI20030352A1 (it)	2004-08-28	Metodo per la sintesi di metiltriossorenio.
DE60321724D1 (de)	2008-07-31	1,2-diaza-dibenzoazulene als inhibitoren der produfür deren herstellung
EP1723125A4 (en)	2009-11-18	1,2,4-benzotriazine-1,4-dioxides
WO2004056762A3 (en)	2004-08-12	Novel aminobenzophenone compounds
FR2888843B1 (fr)	2012-05-04	Procede de preparation d'un diarylanthracene.